This inventor holds 1 USPTO granted patent. Top assignee: Shanghai United Imaging Healthcare Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Runxin Liu: Innovator in Dose Distribution Prediction
Introduction
Runxin Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of healthcare technology, particularly in the area of dose distribution prediction. His innovative work aims to enhance treatment accuracy and patient outcomes.
Latest Patents
Runxin Liu holds a patent for "Methods and systems for dose distribution prediction." This patent outlines methods that involve obtaining historical and current state information of a target subject. The current state information reflects the subject's condition during a treatment fraction, while the historical state information provides insights from prior treatment fractions. The methods also include determining a feature parameter for optimization targets and predicting the current dose distribution using a trained machine learning model.
Career Highlights
Runxin Liu is associated with Shanghai United Imaging Healthcare Co., Ltd., where he applies his expertise in developing advanced healthcare solutions. His work focuses on integrating machine learning techniques to improve treatment planning and delivery.
Collaborations
Runxin Liu collaborates with notable colleagues, including Kejun Zhao and Shuo Liu. Their combined efforts contribute to the advancement of innovative healthcare technologies.
Conclusion
Runxin Liu's contributions to dose distribution prediction exemplify the intersection of technology and healthcare. His innovative methods have the potential to significantly improve treatment outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
